D3017
D3017 is the main metabolite of D2624, which has oral bioactivity and anti-convulsant effects. D3017 ED50 value is 1.5 mg/kg in mice, and it can be used for research on severe generalized tonic-clonic seizures (grand mal) and complex partial epilepsy[1].
Product Specifications
CAS Number
130403-18-8
UNSPSC
12352005
Target
Endogenous Metabolite
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Neurological Disease
Smiles
O=C(C1=NOC(CO)=C1)NC2=C(C)C=CC=C2C
Molecular Formula
C13H14N2O3
Molecular Weight
246.26
References & Citations
[1]F Lepage, et al. New N-aryl isoxazolecarboxamides and N-isoxazolylbenzamides as anticonvulsant agents. Eur JMed Chem (1992) 27,581-593.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
FY-AB35473-01 1 mL
Anti-Matrix Metalloproteinase 9 (MMP9) Polyclonal antibody
Sign In for Pricing
View Details FY-AB35473-02 100 µL
Anti-Matrix Metalloproteinase 9 (MMP9) Polyclonal antibody
Sign In for Pricing
View Details FY-AB35473-03 200 µL
Anti-Matrix Metalloproteinase 9 (MMP9) Polyclonal antibody
Sign In for Pricing
View Details 